Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News £17.9m for Advanced Therapy Treatment Centre network to bolster UK clinical trial infrastructure The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
News BactiVac Network awarded £700k by the UK Vaccine Network Project to focus on potential epidemics
14 July 2023 Birmingham Professor appointed new Chair of the Medical Research Foundation Professor Paul Moss has been appointed as the new Chair of the Medical Research Foundation’s Board of Trustees, with effect from October 2023.
03 March 2023 New research to understand immune responses against COVID-19 vaccination Study received £2.8m of Department of Health and Social Care funding to find out if testing can identify which immunosuppressed people remain at greatest risk.
03 March 2023 AI used to predict future flares of ulcerative colitis activity Ulcerative colitis assessment could be improved after new research shows that an AI model could predict flare-ups and complications after reading biopsies.
21 February 2023 £1 million award for BactiVac Network to continue supporting development of bacterial vaccines Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease.
15 February 2023 Efficacy of BCG vaccine in reducing COPD exacerbations funded for £1.8M University of Birmingham researchers have received a £1.8M grant by the NIHR EME Programme investigating BCG vaccine efficacy in reducing COPD exacerbations.
08 February 2023 Leukaemia trial testing vaccine strategies to combat immune suppression The IMPROVE clinical trial is testing whether vaccine timing can help clinically vulnerable people build antibodies
03 February 2023 Immunocompromised patients remain at higher risk of COVID-19 death in hospital Patients had 44% higher risk of death in hospital compared to those with healthy immune system function